✕
Dr. Rahul Bhargava

Dr. Rahul Bhargava

Principal Director & Head - Hematology, Pediatric Hematology & Bone Marrow Transplant
5.0 450+ Reviews

Speciality Hematology & Bone Marrow Transplant
Hospital Fortis Memorial Research Institute (FMRI), Gurugram
Experience 18+ Years
Location Gurugram / New Delhi, India

Biography

Dr. Rahul Bhargava is one of India's most accomplished and internationally acclaimed Hematologists and Bone Marrow Transplant (BMT) specialists, bringing over 18 years of clinical excellence in hemato-oncology, pediatric hematology, and stem cell transplantation.

He currently serves as Principal Director & Head of the Department of Hematology, Pediatric Hematology, Immunology & Stem Cell Transplant at Fortis Memorial Research Institute (FMRI), Gurugram. Under his direct leadership, his unit has performed more than 1,000 bone marrow transplants—representing one of the highest volumes and success benchmarks across North India.

Dr. Bhargava holds the distinction of being the first clinician in India to successfully perform a stem cell transplant for Multiple Sclerosis. After completing his super-specialization (DM) at the All India Institute of Medical Sciences (AIIMS), New Delhi, he completed a high-level post-doctoral fellowship in Leukemia & Bone Marrow Transplantation at the prestigious Vancouver General Hospital, Canada, gaining extensive expertise in voluntary unrelated donor and umbilical cord blood stem cell transplants.

His clinical practice focuses on autologous, allogeneic, matched sibling, and haploidentical (half-matched) bone marrow transplants for adult and pediatric blood disorders including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), multiple myeloma, Hodgkin and non-Hodgkin lymphomas, thalassemia major, sickle cell disease, and severe aplastic anemia.

Education & Fellowships

  • MBBS - Christian Medical College (CMC), Vellore / Recognized University
  • MD (General Medicine) - Gandhi Medical College, Bhopal (Best Outgoing Resident Award)
  • DM (Clinical Hematology) - All India Institute of Medical Sciences (AIIMS), New Delhi (Best Outgoing Student)
  • Post-DM Fellowship in Leukemia and Bone Marrow Transplantation - Vancouver General Hospital, British Columbia, Canada
  • Specialized Training in Umbilical Cord & Voluntary Stem Cell Transplantation - Vancouver, Canada

Special Interests

Autologous Bone Marrow Transplant Allogeneic Stem Cell Transplant Haploidentical (Half-Matched) BMT Acute Myeloid Leukemia (AML) Acute Lymphoblastic Leukemia (ALL) Multiple Myeloma & CAR-T Therapy Hodgkin & Non-Hodgkin Lymphoma Thalassemia Major Stem Cell Cure Severe Aplastic Anemia Treatment Stem Cell Transplant for Multiple Sclerosis Sickle Cell Disease Care Pediatric Hemato-Oncology

Medical Registrations & Honors

  • Delhi Medical Council (Registration No. 27244)
  • Haryana State Medical Council
  • Medical Council of India (MCI) / National Medical Commission (NMC)
  • Best Outgoing Student in DM Clinical Hematology at AIIMS, New Delhi
  • Best Outgoing Post Graduate Resident Award at Gandhi Medical College
  • Pioneer in establishing affordable, low-cost BMT units across multiple regional centers in India
  • Keynote Speaker & International Educator across Iraq, Uzbekistan, Kenya, Rwanda, and Uganda

List Of Treatments

FAQs

Frequently Asked Questions

Find answers to common questions about Dr. Rahul Bhargava, bone marrow transplants, treatment costs, and international medical logistics.

Dr. Rahul Bhargava is the Principal Director & Head of Hematology, Pediatric Hematology, and Bone Marrow Transplant at Fortis Memorial Research Institute (FMRI), Gurugram. An alumnus of AIIMS New Delhi and Vancouver General Hospital, Canada, he has successfully completed more than 1,000 bone marrow transplants.

Dr. Bhargava performs autologous stem cell transplants (using the patient's own cells), allogeneic transplants (using matched family donors), matched unrelated donor transplants (MUD through national and international registries like DATRI/DKMS), and haploidentical half-matched transplants (using parents or siblings).

Yes. An allogeneic or haploidentical bone marrow transplant is the only definitive cure for beta-thalassemia major and severe sickle cell disease. Dr. Bhargava’s team has cured hundreds of children from India, Africa, and the Middle East, freeing them from lifelong blood transfusion dependencies.

Families can send bone marrow biopsies, flow cytometry reports, HLA typing results, and complete medical summaries to LyfCure. We coordinate a preliminary opinion and customized protocol from Dr. Bhargava, provide an itemized hospital estimate, issue BMT medical visa invitation letters, and organize airport transfers and accommodation close to FMRI Gurugram.